FI932650A0 - Foer skoetsel av B-cellers malignitet avsedda farmaceutiska blandningar - Google Patents

Foer skoetsel av B-cellers malignitet avsedda farmaceutiska blandningar

Info

Publication number
FI932650A0
FI932650A0 FI932650A FI932650A FI932650A0 FI 932650 A0 FI932650 A0 FI 932650A0 FI 932650 A FI932650 A FI 932650A FI 932650 A FI932650 A FI 932650A FI 932650 A0 FI932650 A0 FI 932650A0
Authority
FI
Finland
Prior art keywords
skoetsel
pharmaceutiska
malignitet
cellers
avsedda
Prior art date
Application number
FI932650A
Other languages
English (en)
Other versions
FI932650A (fi
Inventor
Jacques Banchereau
France Thierry De
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of FI932650A0 publication Critical patent/FI932650A0/fi
Publication of FI932650A publication Critical patent/FI932650A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2026IL-4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI932650A 1990-12-13 1993-06-10 Foer skoetsel av B-cellers malignitet avsedda farmaceutiska blandningar FI932650A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90403585A EP0490006B1 (en) 1990-12-13 1990-12-13 Pharmaceutical compositions for the treatment of B-cell malignancies

Publications (2)

Publication Number Publication Date
FI932650A0 true FI932650A0 (fi) 1993-06-10
FI932650A FI932650A (fi) 1993-06-10

Family

ID=8205785

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932650A FI932650A (fi) 1990-12-13 1993-06-10 Foer skoetsel av B-cellers malignitet avsedda farmaceutiska blandningar

Country Status (16)

Country Link
EP (2) EP0490006B1 (fi)
JP (1) JPH06504767A (fi)
AT (1) ATE135232T1 (fi)
AU (1) AU9072191A (fi)
CA (1) CA2098509A1 (fi)
CZ (1) CZ113593A3 (fi)
DE (1) DE69117974T2 (fi)
DK (1) DK0561927T3 (fi)
ES (1) ES2084995T3 (fi)
FI (1) FI932650A (fi)
GR (1) GR3019699T3 (fi)
HU (1) HU210009B (fi)
IE (1) IE64157B1 (fi)
OA (1) OA09788A (fi)
SK (1) SK59193A3 (fi)
WO (1) WO1992010201A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950702838A (ko) * 1992-08-19 1995-08-23 에릭 에스. 딕커 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE145556T1 (de) * 1990-09-06 1996-12-15 Schering Corp Verwendung von interleukin-4 zur behandlung der festen tumoren

Also Published As

Publication number Publication date
JPH06504767A (ja) 1994-06-02
SK59193A3 (en) 1994-01-12
GR3019699T3 (en) 1996-07-31
EP0561927B1 (en) 1996-03-13
CZ113593A3 (en) 1994-01-19
ATE135232T1 (de) 1996-03-15
AU9072191A (en) 1992-07-08
EP0490006B1 (en) 1994-06-22
IE914328A1 (en) 1992-06-17
EP0561927A1 (en) 1993-09-29
DE69117974T2 (de) 1996-07-25
EP0490006A1 (en) 1992-06-17
WO1992010201A1 (en) 1992-06-25
OA09788A (en) 1994-04-15
IE64157B1 (en) 1995-07-12
DE69117974D1 (de) 1996-04-18
DK0561927T3 (da) 1996-07-29
HU9301719D0 (en) 1993-09-28
ES2084995T3 (es) 1996-05-16
HU210009B (en) 1995-01-30
HUT64478A (en) 1994-01-28
CA2098509A1 (en) 1992-06-14
FI932650A (fi) 1993-06-10

Similar Documents

Publication Publication Date Title
ES8801789A1 (es) Un procedimiento para la preparacion de derivados de indol
ES8705393A1 (es) Un procedimiento para preparar un derivado de pirazol (como divisional de la solicitud de patente de invencion n 543.046, presentada el 10.5.85)
NO942641L (no) Inhibisjon av fosfatidylinositol 3-kinase med wortmannin og analoger derav
BG104089A (en) Dolastatine 15 derivatives
GR3022321T3 (en) Use of il-4 to treat solid tumors
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
IN167848B (fi)
FI932650A (fi) Foer skoetsel av B-cellers malignitet avsedda farmaceutiska blandningar
GR3026428T3 (en) Optical isomers of 7- 3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents
CS713183A2 (en) Zpsob vyroby benzenovych derivatu
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
ZA796789B (en) Novel 3,4-diaza-bicyclo (4.1.0) hept-2-en-5-ones, their preparation, and therapeutic agents containing these compounds
AU558461B2 (en) Carbamyloxybenzhyrol derivatives
JPS5695116A (en) Xanthine oxidase inhibitor and therapeutic treatment thereby
JPS57108083A (en) 5-phenyltetrazole compound
SE8204791L (sv) Sett att framstella alkoxivinkaminsyraestrar och alkoxiapovinkaminsyraestrar
ES8400443A1 (es) Mejoras introducidas en un procedimiento para la preparacion de hidroximidatos y tiolhidroximidatos heterobiciclicos y derivados ester carbamato de lso mismos.
ES469426A1 (es) Un procedimiento para la preparacion de derivados n-al- quil-n-iminometilicos de tienamicina
MY102564A (en) An indole derivative

Legal Events

Date Code Title Description
FD Application lapsed